Evidence-based strategies for reducing cardiovascular risk in preterm-born individuals

StrategyEvidence levelKey considerations
Nutritional interventionsModerate (RCTs, observational)Vitamin D supplementation, balanced catch-up growth, omega-3 fatty acids
Blood pressure screeningHigh (guideline-based)Regular pediatric checks, possible 24 h ambulatory BP monitoring for high-risk groups
Echocardiographic follow-upModerate-high (cohort studies)TDI, speckle-tracking for early detection of LV dysfunction, especially in extremely preterm survivors
Lifestyle & exercise programsModerate (some RCTs in pediatrics)Emphasize moderate activity to prevent obesity and insulin resistance
Antihypertensive therapyEmerging evidenceEarly ACE inhibitors or ARBs may halt progression of LV hypertrophy; requires further pediatric trials
Telemedicine & mHealthGrowing (pilot programs, LMICs data)Addresses follow-up gaps, especially in rural/low-resource settings
Environmental exposure mitigationModerate (epidemiological data)Reduction of maternal exposure to toxic metals (lead, mercury, arsenic) and pollutants
Maternal health optimizationHigh (strong epidemiological links)Control of maternal BMI, BP, glycemic status (preconception & prenatal) to lower PTB and subsequent risks

This table highlights selected evidence-based interventions; ongoing research may refine these strategies further. LMICs: low- and middle-income countries; TDI: tissue doppler imaging; BMI: body mass index